Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Herborium Group, Inc. (OTC: HBRM).

Full DD Report for HBRM

You must become a subscriber to view this report.



Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-18N/A0.0001N/AN/A1
2018-12-17N/A0.0001N/AN/A0
2018-12-14N/A0.0001N/AN/A0
2018-12-130.00010.00010.00010.00015,000,001
2018-12-12N/A0.0001N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-101,893,6492,042,87392.6954Short
2018-11-233,300,0008,384,95339.3562Short
2018-11-191,000,0003,000,00033.3333Cover
2018-10-261,990,8631,990,863100.0000Short
2018-10-241,154,5031,154,503100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on HBRM.


About Herborium Group, Inc. (OTC: HBRM)

Logo for Herborium Group, Inc. (OTC: HBRM)

Herborium Group, Inc., is a novel botanical therapeutics company focused on developing, licensing, and marketing of proprietary, botanical based medicinal products, targeting unmet medical needs. The Company responds to both consumers and healthcare professionals demand for safe, efficacious, all natural medicinal options for treatment and prevention of selected diseases and health concerns.

 

 

 

Current Management

  • Agnes Olszewski / President, CEO, Founder
  • James Gilligan / CSO, Founder
  • Agnes Olszewski / Chairwoman
  • James Gilligan /

Current Share Structure

  • Market Cap: $220,295 - 03/16/2018
  • Authorized: 10,000,000,000 - 11/30/2015
  • Issue and Outstanding: 2,202,945,450 - 11/30/2015

 


Recent Filings from (OTC: HBRM)

Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: February, 28 2018
Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current Information
Filing Type: Attorney Letter with Respect to Current Information - Attorney Letter with Respect to Current InformFiling Source: OTC Markets
Filing Date: February, 28 2018
Annual Report - Financial Statements
Filing Type: Annual Report - Financial StatementsFiling Source: OTC Markets
Filing Date: February, 27 2018
Annual Report - Annual Report
Filing Type: Annual Report - Annual ReportFiling Source: OTC Markets
Filing Date: February, 27 2018
Management Discussion and Analysis - Management Discussion and Analysis
Filing Type: Management Discussion and Analysis - Management Discussion and AnalysisFiling Source: OTC Markets
Filing Date: October, 17 2017
Quarterly Report - Quarterly Report
Filing Type: Quarterly Report - Quarterly ReportFiling Source: OTC Markets
Filing Date: October, 13 2017
Quarterly Report - Consolidated Financial Statements
Filing Type: Quarterly Report - Consolidated Financial StatementsFiling Source: OTC Markets
Filing Date: October, 13 2017

 

 


Daily Technical Chart for (OTC: HBRM)

Daily Technical Chart for (OTC: HBRM)


Stay tuned for daily updates and more on (OTC: HBRM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: HBRM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in HBRM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of HBRM and does not buy, sell, or trade any shares of HBRM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/